This topic contains a solution. Click here to go to the answer

Author Question: Which of the following statements is not correct with regards to the Wilcoxon Signed-Rank Test? a. ... (Read 99 times)

MGLQZ

  • Hero Member
  • *****
  • Posts: 579
Which of the following statements is not correct with regards to the Wilcoxon Signed-Rank Test?
 a. In large-sample problems, the Wilcoxon test in usually not less efficient than the t-test and may be more efficient if the underlying distribution is not approximately normal.
 
  b. If the underlying distribution is normal, it is often preferred to use the t test because it will have more power associated.
 
  c. If the sample has an underlying distribution that is normal then either the signed-rank test or the t-test could be used to test hypotheses about .
 
  d. The Wilcoxon signed-rank test is designed for data that are basically symmetric but outlier-prone.

Question 2

In a designed experiment, researchers control for various factors such as age, gender, or socioeconomic status.
 a. True
  b. False
   Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

joewallace

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

c

Answer to Question 2

TRUE




MGLQZ

  • Member
  • Posts: 579
Reply 2 on: Jun 24, 2018
Wow, this really help


Chelseyj.hasty

  • Member
  • Posts: 319
Reply 3 on: Yesterday
Gracias!

 

Did you know?

More than 4.4billion prescriptions were dispensed within the United States in 2016.

Did you know?

The people with the highest levels of LDL are Mexican American males and non-Hispanic black females.

Did you know?

Asthma occurs in one in 11 children and in one in 12 adults. African Americans and Latinos have a higher risk for developing asthma than other groups.

Did you know?

The first war in which wide-scale use of anesthetics occurred was the Civil War, and 80% of all wounds were in the extremities.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library